Atrás
También listada como
TRUMF
OTC
Rango del Día
$13.10
$13.50
Rango de 52 Semanas
$12.15
$20.12
Volumen
53,182
Promedio 50D / 200D
$13.27
/
$15.85
Cierre Anterior
$12.55
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 0.2 | 0.4 |
| P/B | 0.0 | 2.9 |
| ROE % | 8.7 | 3.8 |
| Net Margin % | 11.3 | 3.9 |
| Rev Growth 5Y % | 14.0 | 10.0 |
| D/E | 0.1 | 0.2 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$157.00
$148.22 – $161.77
|
1500 B | 1 |
| FY2029 |
$141.15
$133.25 – $145.44
|
1400 B | 1 |
| FY2028 |
$120.96
$114.19 – $124.63
|
1300 B | 1 |
Puntos Clave
Revenue grew 13.98% annually over 5 years — strong growth
Debt/Equity of 0.13 — conservative balance sheet
Generating 128.44B in free cash flow
P/E of 0.17 — trading at a low valuation
Cash machine — converts 109.80% of earnings into free cash flow
Capital efficient — spends only 7.95% of revenue on capex
Crecimiento
Revenue Growth (5Y)
13.98%
Revenue (1Y)12.40%
Earnings (1Y)9.97%
FCF Growth (3Y)68.27%
Calidad
Return on Equity
8.68%
ROIC7.66%
Net Margin11.29%
Op. Margin15.22%
Seguridad
Debt / Equity
0.13
Current Ratio3.00
Interest Coverage25.24
Valoración
P/E Ratio
0.17
P/B Ratio0.01
EV/EBITDA-0.17
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 12.40% | Revenue Growth (3Y) | 12.40% |
| Earnings Growth (1Y) | 9.97% | Earnings Growth (3Y) | 14.44% |
| Revenue Growth (5Y) | 13.98% | Earnings Growth (5Y) | 10.92% |
| Profitability | |||
| Revenue (TTM) | 1.04T | Net Income (TTM) | 116.98B |
| ROE | 8.68% | ROA | 6.40% |
| Gross Margin | 54.11% | Operating Margin | 15.22% |
| Net Margin | 11.29% | Free Cash Flow (TTM) | 128.44B |
| ROIC | 7.66% | FCF Growth (3Y) | 68.27% |
| Safety | |||
| Debt / Equity | 0.13 | Current Ratio | 3.00 |
| Interest Coverage | 25.24 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 0.17 | P/B Ratio | 0.01 |
| P/S Ratio | 0.02 | PEG Ratio | 3.39 |
| EV/EBITDA | -0.17 | Dividend Yield | 0.01% |
| Market Cap | 19.56B | Enterprise Value | -27.47B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.04T | 921.86B | 820.21B | 703.30B | 613.84B |
| Net Income | 116.98B | 106.37B | 89.33B | 88.81B | 77.27B |
| EPS (Diluted) | 78.99 | 71.47 | 59.48 | 58.69 | 51.05 |
| Gross Profit | 560.67B | 479.18B | 417.37B | 369.34B | 326.62B |
| Operating Income | 157.67B | 140.10B | 117.33B | 115.96B | 98.39B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.83T | 1.83T | 1.60T | 1.47T | 1.35T |
| Total Liabilities | 459.86B | 504.31B | 491.16B | 461.38B | 494.53B |
| Shareholders' Equity | 1.37T | 1.33T | 1.11T | 1.01T | 856.66B |
| Total Debt | 174.84B | 268.55B | 231.94B | 259.01B | 293.08B |
| Cash & Equivalents | 221.87B | 204.88B | 187.32B | 205.25B | 200.77B |
| Current Assets | 723.50B | 722.12B | 611.40B | 558.71B | 523.97B |
| Current Liabilities | 240.97B | 379.15B | 218.00B | 177.72B | 211.37B |
Puntuaciones de Estrategias
This stock passed the criteria for 4 strategies
Score = fit strength (0–100)
Rank = position among all matches
Actividad Reciente
Entró
Cash Flow Compounder
Mar 24, 2026
Entró
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entró
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Entró
Defensive Investing (Benjamin Graham)
Mar 24, 2026